Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Nicholas L Mills, MD nick.mills@ed.ac.uk


Michael McDermott, MBChB 07966024516
michael.mcdermott@ed.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Recruiting

Open to: ALL

Age: 30.0 - N/A

Medical Conditions

Coronary Artery Disease
Angina, Stable
Chest Pain


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


The ORACLE study is an observational cohort study designed to explore the feasibility of providing an assessment of chest pain for patients with suspected angina within one working day of referral to specialist services.

The primary objective is to determine the feasibility of delivering an objective assessment of risk for participants who have been referred by their primary care provider to the rapid access chest pain clinic with possible angina in a community setting using point of care and patient facing technologies within one working day of referral.

Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms.

Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured by point of care high sensitivity cardiac troponin assays as well as a core lab assay.

The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jul 2024 May 2025

OBSERVATIONAL

Intervention Type : OTHER
Intervention Description : Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms.

Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured.

The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events.

Intervention Arm Group : Patients with possible angina;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • NHS Lothian
    Edinburgh

Nicholas L Mills, MD nick.mills@ed.ac.uk


Michael McDermott, MBChB 07966024516
michael.mcdermott@ed.ac.uk



The study is sponsored by University of Edinburgh




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT06325020
Last updated 27 November 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.